Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001037051 | SCV001200445 | uncertain significance | Joubert syndrome 14 | 2022-06-20 | criteria provided, single submitter | clinical testing | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 98 of the TMEM237 protein (p.Thr98Ile). This variant has not been reported in the literature in individuals affected with TMEM237-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 836030). |
Ambry Genetics | RCV004686628 | SCV005175562 | uncertain significance | Inborn genetic diseases | 2024-05-10 | criteria provided, single submitter | clinical testing | The c.293C>T (p.T98I) alteration is located in exon 6 (coding exon 6) of the TMEM237 gene. This alteration results from a C to T substitution at nucleotide position 293, causing the threonine (T) at amino acid position 98 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |